Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | |||||
---|---|---|---|---|---|---|---|---|---|
Protein | P value | Protein | P value | Protein | P value | Protein | P value | Protein | P value |
Dermatological diseases and conditions | 1.25E−04 to 3.17E−25 | Inflammatory response | 4.02E−03 to 1.91E−10 | Inflammatory response | 3.49E−04 to 9.03E−20 | Metabolic disease | 2.52E−04 to 1.54E−16 | Metabolic disease | 2.69E−03 to 1.27E−14 |
Organismal injury and abnormalities | 2.03E−04 to 3.17E−25 | Organismal injury and abnormalities | 4.02E−03 to 1.91E−10 | Organismal injury and abnormalities | 3.49E−04 to 9.03E−20 | Connective tissue disorders | 3.72E−04 to 6.67E−16 | Inflammatory response | 2.55E−03 to 2.94E−14 |
Metabolic disease | 1.89E−04 to 3.65E−23 | Hematological disease | 3.44E−03 to 3.53E−10 | Metabolic disease | 3.18E−04 to 7.41E−18 | Inflammatory disease | 5.16E−04 to 6.67E−16 | Hematological disease | 2.32E−03 to 2.21E−13 |
Inflammatory response | 1.87E−04 to 1.24E−21 | Immunological disease | 3.44E−03 to 3.53E−10 | Neurological disease | 2.91E−04 to 6.16E−15 | Inflammatory response | 5.16E−04 to 6.67E−16 | Immunological disease | 1.95E−03 to 2.21E−13 |
Neurological disease | 2.03E−04 to 1.37E−21 | Inflammatory disease | 2.94E−03 to 3.53E−10 | Psychological disorders | 2.55E−04 to 6.16E−15 | Organismal injury and abnormalities | 5.16E−04 to 6.67E−16 | Inflammatory disease | 2.55E−03 to 2.21E−13 |